More than 30,271 health professionals from 174 countries attended this year’s event, which covered the entire field of cardiovascular medicine at ESC22
September 01, 2022
Best of ESC Congress 2022
September 1, 2022 — “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective…
Read More
Comatose patients admitted to hospital after resuscitation from out-of-hospital cardiac arrest have a significant risk of death and poor neurological outcome due to hypoxic brain injury.
September 01, 2022
Trial Finds no Benefit of Raising Blood Pressure Target in Post Cardiac Arrest Patients
September 1, 2022 — A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in…
Read More
ALL-HEART trial presented in a Hot Line Session at ESC Congress 2022
September 01, 2022
Allopurinol Does Not Improve Cardiovascular Outcomes in Ischaemic Heart Disease Patients
September 1, 2022 — The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial…
Read More
BioIntelliSense's new BioButton for 90-days of continuous wireless temperature and vital signs monitoring on a coin-sized disposable medical device
August 31, 2022
Medtronic Announces Partnership with BioIntelliSense for Exclusive U.S. Distribution of Multi-Parameter Wearable for Continuous Remote Patient Monitoring from in-Hospital to Home 
August 31, 2022 — Medtronic plc, a global leader in healthcare technology, announced it has entered into a strategic…
Read More
Healthcare providers should promote prevention of atrial fibriliation, an abnormal heart rhythm disturbance, and early interventions among both female and male patients, say Cedars-Sinai investigators. Photo by Getty Images.
August 31, 2022
Gender Differences and AFib: New Study Flips Conventional Wisdom
August 31, 2022 — Science has long shown that men are at greater risk for developing atrial fibrillation (AFib) than…
Read More
70-year-old White male patient with weight of 79.8 kg, BMI of 29.3, low cardiovascular risk factors (nonsmoker, no diabetes diagnosis, blood pressure of 120/78). Left: Axial CT image at level of L3 vertebral body. Right: Matching automated segmentation label map. Visceral fat area z score is 1.41, corresponding to the 92nd percentile. Patient experienced both subsequent myocardial infarction and stroke.
August 31, 2022
CT-Derived Body Composition With Deep Learning Predicts Cardiovascular Events
August 31, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), fully automated and normalized body…
Read More
A clinician using Ultrasound Workspace from Philips
August 30, 2022
Philips Spotlights Integrated, Data-Driven Cardiology Solutions at ESC 2022
August 30, 2022 —  Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its latest…
Read More
SECURE trial presented in a Hot Line Session today at ESC Congress 2022
August 30, 2022
Polypill Reduces Cardiovascular Events in Heart Attack Patients Compared to Usual Care
August 30, 2022 — A pill containing aspirin and medications to lower lipids and blood pressure more effectively…
Read More
The MOMENTUM 3 study showcases the significant survival benefits of Abbott's heart pump technology, particularly in a patient population with limited therapy options
August 30, 2022
New Data Show Abbott's Heartmate 3 Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure Patients
August 30, 2022 — Abbott announced new late-breaking data that show its HeartMate 3 heart pump extends survival of…
Read More
Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success
August 29, 2022
FARXIGA Significantly Reduced the Risk of Cardiovascular Death or Worsening of Heart Failure in Patients with Mildly Reduced or Preserved Ejection Fraction in DELIVER Phase III Trial
August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin)…
Read More
Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success
August 29, 2022
Medtronic Extravascular ICD meets global pivotal clinical trial’s safety and effectiveness endpoints
August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator…
Read More
Amarin Corporation plc announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl) significantly reduced cardiovascular (CV) events in patients with a history of smoking. 
August 29, 2022
New REDUCE-IT Data Released at ESC Oral Presentation Session
August 29, 2022 — Amarin Corporation plc announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl)…
Read More
A study from the Smidt Heart Institute and Cedars-Sinai's Division of Artificial Intelligence in Medicine shows that AI was more accurate in diagnosing cardiac function than sonographers. Illustration by Getty.
August 29, 2022
Late-Breaking Heart Research: AI More Accurate Than Technicians
August 29, 2022 — In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and…
Read More
The USPSTF has issued a Recommendation Statement, relating to Statin Use for the Primary Prevention of Cardiovascular Disease in Adults
August 29, 2022
USPSTF Issues Statin Recommendation Statement
August 29, 2022 — ­The US Preventive Services Task Force (USPSTF) has issued a Recommendation Statement, relating to…
Read More
COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure, according to research presented at ESC Congress 2022.
August 26, 2022
COVID mRNA Vaccines are Safe in Patients with Heart Failure
August 26, 2022 — COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure, …
Read More
A new Cedars-Sinai study is the first study proven to be effective at identifying coronary artery disease patients at highest risk for sudden cardiac death. Photo by Cedars-Sinai.
August 26, 2022
Genetic Score Detects Those at Risk for Sudden Cardiac Death
August 26, 2022 — Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients…
Read More
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that the program is now available for the TCT MedTech Innovation Forum.
August 26, 2022
CRF and Fogarty Innovation Announce Agenda for TCT MedTech Innovation Forum
August 26, 2022 — The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that the program…
Read More
Jamshid Maddahi, MD, FASNC
August 25, 2022
Late Breaking Flurpiridaz Trial Results at ASNC2022
August 25, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron…
Read More
Imperfect current propagation in the heart is at the root of most cardiac diseases
August 25, 2022
Measuring Currents in the Heart at Millimeter Resolution with a Diamond Quantum Sensor
August 25, 2022 — Imperfect current propagation in the heart is at the root of most cardiac diseases. Thanks to a novel…
Read More
Independent Data Presented at the World Federation of Interventional and Therapeutic Neuroradiology 2022 Annual Meeting Highlights the Benefits of Vessel-Matching with Zoom Reperfusion Catheters
August 25, 2022
Imperative Care Announces Positive New Data Underscoring the Safety and Efficacy of the Zoom Stroke Solution to Treat Distal Occlusions in Ischemic Stroke Patients
August 25, 2022 — Imperative Care, Inc. announced that new data evaluating the utility of the Zoom Stroke Solution were…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now